Satishkumar Ramraj
Overview
Explore the profile of Satishkumar Ramraj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elayapillai S, Ramraj S, Benbrook D, Bieniasz M, Wang L, Pathuri G, et al.
Gynecol Oncol
. 2020 Nov;
160(1):302-311.
PMID: 33131904
Objective: Mebendazole and other anti-parasitic drugs are being used off-prescription based on social media and unofficial accounts of their anti-cancer activity. The purpose of this study was to conduct a...
2.
Aravindan S, Ramraj S, Kandasamy K, Thirugnanasambandan S, Somasundaram D, Herman T, et al.
Oncotarget
. 2016 Dec;
8(4):5717-5734.
PMID: 27974694
Therapy-resistant pancreatic cancer (PC) cells play a crucial role in tumor relapse, recurrence, and metastasis. Recently, we showed the anti-PC potential of an array of seaweed polyphenols and identified efficient...
3.
Pandian V, Ramraj S, Khan F, Azim T, Aravindan N
Stem Cell Res Ther
. 2016 Feb;
7:32.
PMID: 26892617
No abstract available.
4.
Paari A, Paulraj K, Ramraj S, Neelkandan Y, Vellaiyan P, Siva P, et al.
Probiotics Antimicrob Proteins
. 2016 Jan;
3(2):103-11.
PMID: 26781574
The influence of Streptococcus phocae PI80 on the shelf life of Sardinella longiceps and Penaeus monodon was investigated by measurement of microbial and chemical analysis after appraising the safety of...
5.
Khan F, Pandian V, Ramraj S, Natarajan M, Aravindan S, Herman T, et al.
BMC Cancer
. 2015 Jul;
15:514.
PMID: 26159519
Background: Determining the driving factors and molecular flow-through that define the switch from favorable to aggressive high-risk disease is critical to the betterment of neuroblastoma cure. Methods: In this study,...
6.
Khan F, Pandian V, Ramraj S, Aravindan S, Herman T, Aravindan N
BMC Genomics
. 2015 Jul;
16:501.
PMID: 26148557
Background: MetastamiRs have momentous clinical relevance and have been correlated with disease progression in many tumors. In this study, we identified neuroblastoma metastamiRs exploiting unique mouse models of favorable and...
7.
Pandian V, Ramraj S, Khan F, Azim T, Aravindan N
Stem Cell Res Ther
. 2015 Apr;
6:2.
PMID: 25888913
Introduction: High-risk neuroblastoma (HR-NB) presenting with hematogenous metastasis is one of the most difficult cancers to cure. Patient survival is poor. Aggressive tumors contain populations of rapidly proliferating clonogens that...